Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 13, 2020 Filed Aug 17, 2020 18:42 UTC
Young James MCorporate SVP and CFO
SaleCommon Stock 9,536 $138.91 $1,324,645.76
Disclosure

SEC source: 0001225208-20-010679 · doc4.xml · nonDerivative · entry 3

Young James M · CIK 0001610934 · Corporate SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,769

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.20 - $139.973, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
August 13, 2020 Filed Aug 17, 2020 18:42 UTC
Young James MCorporate SVP and CFO
Exercise / conversionCommon Stock 10,245 $98.31 $1,007,185.95
Disclosure

SEC source: 0001225208-20-010679 · doc4.xml · nonDerivative · entry 2

Young James M · CIK 0001610934 · Corporate SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,305

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 13, 2020 Filed Aug 17, 2020 18:42 UTC
Young James MCorporate SVP and CFO
Exercise / conversionCommon Stock 19,699 $93.88 $1,849,342.12
Disclosure

SEC source: 0001225208-20-010679 · doc4.xml · nonDerivative · entry 1

Young James M · CIK 0001610934 · Corporate SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,060

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 10:47 UTC
Matlin LauraVP, Deputy GC and CGO
GrantCommon Stock 859 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010349 · doc4.xml · nonDerivative · entry 1

Matlin Laura · CIK 0001658944 · VP, Deputy GC and CGO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,074.696

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 10:47 UTC
Mayadas VijayCorporate Vice President
GrantCommon Stock 1,593 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010350 · doc4.xml · nonDerivative · entry 1

Mayadas Vijay · CIK 0001658677 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,892.756

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 10:46 UTC
Liberatore MichaelVP, ICS - Mutual Funds
GrantCommon Stock 1,812 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010348 · doc4.xml · nonDerivative · entry 1

Liberatore Michael · CIK 0001659018 · VP, ICS - Mutual Funds

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,659.91

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:46 UTC GrantCommon Stock 19,956 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010346 · doc4.xml · nonDerivative · entry 1

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,038.0271

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 10:46 UTC
DALY RICHARD JDirector · Executive Chairman
GrantCommon Stock 32,534 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010344 · doc4.xml · nonDerivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,268.9949

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:47 UTC
Young James MCorporate SVP and CFO
GrantCommon Stock 9,062 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010355 · doc4.xml · nonDerivative · entry 1

Young James M · CIK 0001610934 · Corporate SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,361

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:47 UTC
Taylor Julie R.Corporate VP and CHRO
GrantCommon Stock 3,020 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010354 · doc4.xml · nonDerivative · entry 1

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,073.327

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:47 UTC
Tae Michael SCorporate VP, Corp. Strategy
GrantCommon Stock 1,928 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010353 · doc4.xml · nonDerivative · entry 1

Tae Michael S · CIK 0001663476 · Corporate VP, Corp. Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,739

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:47 UTC
SCHIFELLITE ROBERTCorporate SVP
GrantCommon Stock 6,195 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010352 · doc4.xml · nonDerivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,639.6729

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:47 UTC GrantCommon Stock 4,136 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010351 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,885.528

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:46 UTC
KALENKA ROBERT FCorporate Vice President
GrantCommon Stock 1,975 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010347 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,412.4097

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:46 UTC
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
GrantCommon Stock 2,053 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010345 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,502.8948

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:46 UTC
Carey Thomas PCorporate VP
GrantCommon Stock 1,858 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010343 · doc4.xml · nonDerivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,810

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 6, 2021.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 14:46 UTC
AMSTERDAM ADAM DCorporate Vice President
GrantCommon Stock 4,558 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-010342 · doc4.xml · nonDerivative · entry 1

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,757.3989

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2021.

Read SEC document
July 06, 2020 Filed Jul 7, 2020 20:12 UTC
Taylor Julie R.Corporate VP and CHRO
Exercise / conversionStock Option (Right to Buy) · Derivative 3,415 $0.00 Strike: $98.31 $0.00
Disclosure

SEC source: 0001225208-20-009630 · doc4.xml · derivative · entry 3

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,246

Underlying: Common Stock · 3,415 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2020.

Read SEC document
July 06, 2020 Filed Jul 7, 2020 20:12 UTC
Taylor Julie R.Corporate VP and CHRO
SaleCommon Stock 3,203 $130.00 $416,390.00
Disclosure

SEC source: 0001225208-20-009630 · doc4.xml · nonDerivative · entry 2

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,053.327

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2020.

Read SEC document
July 06, 2020 Filed Jul 7, 2020 20:12 UTC
Taylor Julie R.Corporate VP and CHRO
Exercise / conversionCommon Stock 3,415 $98.31 $335,728.65
Disclosure

SEC source: 0001225208-20-009630 · doc4.xml · nonDerivative · entry 1

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,256.327

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2020.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 20:08 UTC GrantCommon Stock 68 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009629 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,700

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 13:51 UTC GrantCommon Stock 68 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009563 · doc4.xml · nonDerivative · entry 1

PERNA THOMAS J · CIK 0001209487 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,678

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 16:07 UTC
WEBER ALAN JDirector
GrantCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009627 · doc4.xml · nonDerivative · entry 2

WEBER ALAN J · CIK 0001198093 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,677

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 16:07 UTC
WEBER ALAN JDirector
GrantCommon Stock 68 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009627 · doc4.xml · nonDerivative · entry 1

WEBER ALAN J · CIK 0001198093 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,671

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 20:02 UTC
keller brettDirector
GrantCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009625 · doc4.xml · nonDerivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,719

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 20:02 UTC
keller brettDirector
GrantCommon Stock 21 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009625 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,718

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 16:12 UTC GrantCommon Stock 98 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009631 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,093

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 7, 2020 20:08 UTC GrantCommon Stock 9 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009628 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,205

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 17:51 UTC
Zavery AmitDirector
GrantCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009564 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,566

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 17:51 UTC
Zavery AmitDirector
GrantCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009564 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,564

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 17:51 UTC GrantCommon Stock 5 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009562 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,448

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 17:51 UTC GrantCommon Stock 42 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009562 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,443

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2020 Filed Aug 27, 2020 18:23 UTC OtherCommon Stock 33.122 $127.41 $4,220.07
Disclosure

SEC source: 0001225208-20-011026 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,521.102

F1 · kind: Represents shares of Broadridge common stock acquired through dividend reinvestment during the fiscal year.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 12:47 UTC
WEBER ALAN JDirector
GrantCommon Stock 251 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009087 · doc4.xml · nonDerivative · entry 1

WEBER ALAN J · CIK 0001198093 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,603

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 16:48 UTC
keller brettDirector
GrantCommon Stock 220 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009089 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,697

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 16:47 UTC
Zavery AmitDirector
GrantCommon Stock 214 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009088 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,562

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 16, 2020 Filed Jun 18, 2020 16:46 UTC GrantCommon Stock 220 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009086 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,401

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 17:22 UTC
SCHIFELLITE ROBERTCorporate SVP
Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $36.97 $0.00
Disclosure

SEC source: 0001225208-20-008697 · doc4.xml · derivative · entry 4

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,759

Underlying: Common Stock · 20,000 shares

Expires 2024-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 17:22 UTC
SCHIFELLITE ROBERTCorporate SVP
SaleCommon Stock 16,408 $126.64 $2,077,986.24
Disclosure

SEC source: 0001225208-20-008697 · doc4.xml · nonDerivative · entry 3

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,444.6729

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.24 - $127.35, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 17:22 UTC
SCHIFELLITE ROBERTCorporate SVP
SaleCommon Stock 9,592 $126.64 $1,214,775.96
Disclosure

SEC source: 0001225208-20-008697 · doc4.xml · nonDerivative · entry 2

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,852.6729

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.24 - $127.35, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 17:22 UTC
SCHIFELLITE ROBERTCorporate SVP
Exercise / conversionCommon Stock 20,000 $36.97 $739,400.00
Disclosure

SEC source: 0001225208-20-008697 · doc4.xml · nonDerivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,444.6729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 16:37 UTC
Taylor Julie R.Corporate VP and CHRO
Exercise / conversionStock Option (Right to Buy) · Derivative 5,969 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-20-008695 · doc4.xml · derivative · entry 6

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,969

Underlying: Common Stock · 5,969 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2020.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 16:37 UTC
Taylor Julie R.Corporate VP and CHRO
Exercise / conversionStock Option (Right to Buy) · Derivative 4,930 $0.00 Strike: $51.95 $0.00
Disclosure

SEC source: 0001225208-20-008695 · doc4.xml · derivative · entry 5

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,930 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2020.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 16:37 UTC
Taylor Julie R.Corporate VP and CHRO
SaleCommon Stock 5,591 $125.51 $701,752.13
Disclosure

SEC source: 0001225208-20-008695 · doc4.xml · nonDerivative · entry 4

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,841.327

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.02 - $126.1150, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 16:37 UTC
Taylor Julie R.Corporate VP and CHRO
SaleCommon Stock 4,191 $126.10 $528,488.87
Disclosure

SEC source: 0001225208-20-008695 · doc4.xml · nonDerivative · entry 3

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,432.327

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.01 - $126.20, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 16:37 UTC
Taylor Julie R.Corporate VP and CHRO
Exercise / conversionCommon Stock 4,930 $51.95 $256,113.50
Disclosure

SEC source: 0001225208-20-008695 · doc4.xml · nonDerivative · entry 2

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,623.327

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2020.

Read SEC document
June 05, 2020 Filed Jun 8, 2020 16:37 UTC
Taylor Julie R.Corporate VP and CHRO
Exercise / conversionCommon Stock 5,969 $93.88 $560,369.72
Disclosure

SEC source: 0001225208-20-008695 · doc4.xml · nonDerivative · entry 1

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,693.327

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2020.

Read SEC document
June 04, 2020 Filed Jun 4, 2020 16:20 UTC
Mayadas VijayCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 13,706 $0.00 Strike: $26.00 $0.00
Disclosure

SEC source: 0001225208-20-008640 · doc4.xml · derivative · entry 3

Mayadas Vijay · CIK 0001658677 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 13,706 shares

Expires 2023-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 04, 2020 Filed Jun 4, 2020 16:20 UTC
Mayadas VijayCorporate Vice President
SaleCommon Stock 11,180 $123.31 $1,378,574.50
Disclosure

SEC source: 0001225208-20-008640 · doc4.xml · nonDerivative · entry 2

Mayadas Vijay · CIK 0001658677 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,299.756

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.06 - $123.79, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
June 04, 2020 Filed Jun 4, 2020 16:20 UTC
Mayadas VijayCorporate Vice President
Exercise / conversionCommon Stock 13,706 $26.00 $356,356.00
Disclosure

SEC source: 0001225208-20-008640 · doc4.xml · nonDerivative · entry 1

Mayadas Vijay · CIK 0001658677 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,479.756

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.